Rachael Lester
CIK: 0002094324
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTMX
CytomX Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Lester Rachael
Lester Rachael (SEC CIK 0002094324) files insider reports with the SEC as Chief Business Officer of CytomX Therapeutics, Inc. (CTMX).
Signal8 holds 3 ownership filings by Lester Rachael (1 Form 3, 2 Form 4), filed between Oct 29, 2025 and Feb 4, 2026. Those filings report 2 transactions, from Oct 20, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lester Rachael's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Lester Rachael
Other insiders filing for CytomX Therapeutics, Inc. (CTMX)
- McCarthy Sean A., CEO
- Carvajal Alejandra, Chief Legal Officer
- Fuchs Charles S., Director
- Su Zhen, Director
- Young Matthew P., Director
- Mohindru Mani, Director